microfluidics Oct 29, 2021 Qiagen, NeuMoDx Lose Patent Appeal in BD/HandyLab Dispute Sep 27, 2021 TE Connectivity to Expand IVD Offerings With Acquisition of Companies Aug 25, 2021 Single-Molecule Microfluidic ELISA Platform Holds Promise for Rapid Bedside Diagnostics Premium May 25, 2021 UCSC, BYU Team Developing 'Ultrasensitive' Optofluidic Antigen Test for SARS-CoV-2, Flu Premium May 20, 2021 With Finder Platform, Baebies Works to Expand Options for Neonatal Dx Testing Premium Apr 12, 2021 Singapore, MIT Researchers Develop Immune Response Test to Improve Infectious Disease Diagnosis Premium Mar 31, 2021 Biocept Prepares for First FDA Foray With CSF Liquid Biopsy Brain Metastases Assay Premium Mar 29, 2021 Biocept Q4 Revenues Spike as COVID-19 Testing Continues to Soar, Core Cancer Tests Lag Feb 10, 2021 Fluidigm Q4 Revenues Grow 38 Percent on COVID-19-Driven Microfluidics Growth Jan 25, 2021 Fluxergy Aiming to Provide Low-Cost, Multimodal Testing for SARS-CoV-2, Other Disease Targets Premium Dec 28, 2020 COVID-19 Pandemic Accelerated Development of CRISPR as a Diagnostic Platform in 2020 Dec 14, 2020 Imec Preparing Breath Test for SARS-CoV-2 Nov 18, 2020 Stanford Researchers Combine CRISPR, Microfluidics, Electric Fields for SARS-CoV-2 Dx Nov 9, 2020 Savran Technologies to Target Breast Cancer Recurrence with Circulating Tumor Cell Platform Nov 5, 2020 Fluidigm Q3 Revenues Jump 50 Percent Driven by COVID-19 Testing Oct 8, 2020 Fluidigm to Offer Coronavirus Saliva Test to US Colleges, Universities at Low Cost Sep 29, 2020 Fluidigm Finalizes $34M NIH Contract for SARS-CoV-2 Assay Production Sep 8, 2020 Scope Fluidics Secures €10M Loan From European Investment Bank Sep 8, 2020 Fluidigm Raises $20.9M in Equity Offering, Will Receive $11M After Achieving NIH Milestone Aug 26, 2020 Fluidigm Saliva Test for SARS-CoV-2 Gets FDA Emergency Use Authorization Load More Breaking News Rady Children's, PlumCare RWE Partner to Expand WGS-Based Newborn Screening Program to Greece Roche Gets CE Mark for New Version of Rapid Test for Antibodies Against SARS-CoV-2 Broader Market Drags 360Dx Top 30 Down in September Olive Diagnostics Nabs CE Mark for Optical Urinalysis Device Top Five Articles on 360Dx Last Week: Congress and VALID Act; FDA Updates EUA Policy; and More In Brief This Week: Becton Dickinson, Bionano, Yourgene, More
